Document Detail


Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
MedLine Citation:
PMID:  8102097     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The roles of GH and insulin-like growth factor-I (IGF-I) in the regulation of hypothalamic GH-releasing hormone (GRH) and somatostatin (SRIH) gene expression were investigated in the GH-deficient dwarf (dw) rat, in which endogenous feedback signals are lacking. Adult male and female dw rats were treated with GH or IGF-I by systemic (sc) administration or intracerebroventricular (icv) infusion, and hypothalamic GRH and SRIH mRNA were determined by Northern blotting and densitometric analysis. Systemic sc injection of rGH (75 micrograms every 12 h for 3 days) decreased GRH mRNA levels in both sexes. However, systemic sc injection of human IGF-I (150 micrograms every 12 h for 3 days) did not affect GRH mRNA levels in either sex despite significant stimulation of body weight gain. The use of a continuous sc infusion, which normalized serum IGF-I levels, and prolongation of the treatment period to 7 days also failed to change GRH mRNA levels. SRIH mRNA was unaffected by systemic administration of either GH or IGF-I. Continuous icv infusion of GH (1 microgram/h for 7 days) decreased GRH mRNA levels in both sexes, but did not alter SRIH mRNA levels. Continuous icv infusion of IGF-I (100 ng/h for 7 days) decreased GRH mRNA in both sexes. In contrast, SRIH mRNA levels were increased in both sexes. IGF-I decreased GRH mRNA levels at icv infusion rates of 100 and 300 ng/h and stimulated SRIH mRNA levels at infusion rates of 30 and 100 ng/h. Food intake was unaffected at these infusion rates. Changes in GRH and SRIH mRNA levels in response to systemic or central GH and IGF-I administration were similar in both sexes, except that the decrease in GRH mRNA levels produced by the icv infusion of IGF-I was greater in female than in male rats. The results provide evidence for a direct inhibitory feedback effect of GH in the central nervous system on the regulation of hypothalamic GRH gene expression that is independent of peripheral IGF-I. IGF-I feedback, in contrast, appears to originate with central nervous system-derived IGF-I and exhibits a stimulatory effect on SRIH mRNA as well as an inhibitory effect on GRH mRNA.
Authors:
M Sato; L A Frohman
Related Documents :
8708537 - Induction and involvement of endogenous igf-i in pancreas regeneration after partial pa...
9510027 - Differential expression of mam-subfamily protein tyrosine phosphatases during mouse dev...
9408887 - Regulation of ptp1d mrna by peptide growth factors in the human endometrial cell line h...
22490077 - Decorin expression, straw-like structure, and differentiation of human costal cartilage.
9704637 - Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (mmp-1)...
7490157 - Biological determinants of aldosterone-induced cardiac fibrosis in rats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Endocrinology     Volume:  133     ISSN:  0013-7227     ISO Abbreviation:  Endocrinology     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-09-03     Completed Date:  1993-09-03     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  793-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, University of Cincinnati, College of Medicine, Ohio 45267.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Northern
Cerebral Ventricles / drug effects
Dose-Response Relationship, Drug
Dwarfism / metabolism*
Female
Gene Expression / drug effects
Growth Hormone / administration & dosage,  deficiency,  pharmacology*
Growth Hormone-Releasing Hormone / genetics*
Hypothalamus / drug effects,  metabolism*
Insulin-Like Growth Factor I / administration & dosage,  pharmacology*
Male
RNA, Messenger / metabolism
Rats
Rats, Mutant Strains
Somatostatin / genetics*
Grant Support
ID/Acronym/Agency:
DK-30667/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/RNA, Messenger; 51110-01-1/Somatostatin; 67763-96-6/Insulin-Like Growth Factor I; 9002-72-6/Growth Hormone; 9034-39-3/Growth Hormone-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thyroid hormone and dietary carbohydrate induce different hepatic zonation of both "spot 14" and ace...
Next Document:  Do gonadotropin-releasing hormone, tyrosine hydroxylase-, and beta-endorphin-immunoreactive neurons ...